[CAS NO. 541550-19-0]  Apilimod (STA-5326)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [541550-19-0]

Catalog
SLK-S6414
Brand
Selleck
CAS
541550-19-0

DESCRIPTION [541550-19-0]

Overview

MDLMFCD09954108
Molecular Weight418.49
Molecular FormulaC23H26N6O2
SMILESN(N=CC1=CC(C)=CC=C1)C2=CC(=NC(OCCC3=CC=CC=N3)=N2)N4CCOCC4

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.3895 mL11.9477 mL23.8954 mL
5 mM0.4779 mL2.3895 mL4.7791 mL
10 mM0.2390 mL1.1948 mL2.3895 mL
50 mM0.0478 mL0.2390 mL0.4779 mL

Description

Apilimod (STA-5326) is a potent and orally-available inhibitor of the cytokines and with the potential to treat certain autoimmune and inflammatory diseases. Apilimod (STA-5326) inhibits IL-12 with IC50 of 1 nM, 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs, human monocytes and mouse PBMCs, respectively. Apilimod (STA-5326) is also a cell permeable small molecule that specifically inhibits with IC50 of 14 nM.

Targets

IL-12 [1]
( in IFN-γ/SAC-stimulated human PBMCs)
IL-12 [1]
(in human monocytes)
IL-12 [1]
(in mouse PBMCs)
PIKfyve [1]
1 nM1 nM2 nM14 nM

In vitro

Apilimod selectively inhibits TLR-induced cytokine expression. It selectively inhibits the production of IL12p40, whereas it has little effect on IL8 production in THP-1 cells.Apilimod reduces not only PtdIns(3,5)P production but also that of PtdIns5P in intact cells.


Synonyms

Benzaldehyde, 3-methyl-, 2-[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone
Benzaldehyde, 3-methyl-, [6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone
Apilimod
STA 5326